BLMH

gene product
BH
Bleomycin hydrolase (BMH) is a cytoplasmic cysteine peptidase that is highly conserved through evolution; however, the only known activity of the enzyme is metabolic inactivation of the glycopeptide bleomycin (BLM), an essential component of combination chemotherapy regimens for cancer. The protein contains the signature active site residues of the cysteine protease papain superfamily. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
242 antibodies from 26 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
85 antibodies
Proteintech Group
1 antibody
Novus Biologicals
9 antibodies
NovoPro Bioscience Inc.
8 antibodies
Atlas Antibodies
2 antibodies
Biorbyt
12 antibodies
Bioworld Technology, Inc
1 antibody
St John's Laboratory
1 antibody
LifeSpan BioSciences, Inc.
61 antibodies
Abnova Corporation
4 antibodies
R&D Systems
2 antibodies
Invitrogen Antibodies
4 antibodies
Abgent
4 antibodies
MyBioSource
11 antibodies
OriGene
4 antibodies
Aviva Systems Biology
2 antibodies
GeneTex
2 antibodies
ProSci
1 antibody
United States Biological
14 antibodies
Affinity Biosciences
1 antibody
Boster Biological Technology
1 antibody
Creative Biolabs
4 antibodies
Sino Biological Inc.
2 antibodies
Sigma-Aldrich
3 antibodies
Acris Antibodies GmbH
2 antibodies
GenWay
1 antibody